Chronic pain clinical trials in Mississauga, Ontario

Name: Chronic pain clinical trials in Mississauga
Creator: Chronic Pain Canada

Trials

Recruiting or not yet

Trial sites

Trials with a site in Mississauga

7 trials, recruiting first

		Phase
The ECEALT Chronic Low Back Pain Study NCT05040633	Unknown status	Not applicable	Health Rehab and Research Clinic	2022-10-01
The Efficacy of CALPXT96™in Improving Sleep Quality in Patients With Chronic Non-cancer Pain NCT02232256	Withdrawn	Phase 3	9305-9954 Quebec Inc	2015-12
Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina NCT01659580	Completed	Phase 3	Tasly Pharmaceuticals, Inc.	2012-08
A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain NCT00973141	Terminated	Phase 2	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	2009-09-16
A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Low Back Pain NCT00973024	Terminated	Phase 2	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	2009-09
An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain NCT00487435	Completed	Phase 3	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	2007-06
A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain NCT00361504	Completed	Phase 3	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	2006-11

Facility names are as entered by study registrants. This is not a clinic directory.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.